Kestra Medical Technologies (NASDAQ:KMTS) Earns Buy Rating from Analysts at Bank of America

Bank of America began coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a research report report published on Monday, Marketbeat reports. The firm issued a buy rating and a $30.00 target price on the stock.

KMTS has been the subject of a number of other reports. The Goldman Sachs Group initiated coverage on shares of Kestra Medical Technologies in a report on Monday. They issued a “neutral” rating and a $24.00 price target for the company. Wolfe Research initiated coverage on Kestra Medical Technologies in a research report on Monday. They set an “outperform” rating and a $29.00 target price on the stock. Wells Fargo & Company started coverage on Kestra Medical Technologies in a report on Monday. They issued an “overweight” rating and a $28.00 price target for the company. Stifel Nicolaus initiated coverage on Kestra Medical Technologies in a report on Monday. They set a “buy” rating and a $28.00 price objective on the stock. Finally, Piper Sandler assumed coverage on Kestra Medical Technologies in a research report on Monday. They issued an “overweight” rating and a $27.00 target price for the company. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $27.67.

Kestra Medical Technologies Price Performance

Shares of KMTS stock opened at $25.70 on Monday. Kestra Medical Technologies has a 12 month low of $20.00 and a 12 month high of $26.06.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.